Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease
暂无分享,去创建一个
B. Beghé | L. Fabbri | A. Papi | G. Caramori | M. Saetta
[1] P. Paggiaro,et al. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease , 1998, The Lancet.
[2] J. Collet,et al. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. , 1997, American journal of respiratory and critical care medicine.
[3] D. Postma,et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. , 1997, The New England journal of medicine.
[4] A. Kelly,et al. Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma. , 1997, The Journal of allergy and clinical immunology.
[5] R. Rodríguez-Roisín. Acute severe asthma: pathophysiology and pathobiology of gas exchange abnormalities. , 1997, The European respiratory journal.
[6] J. Barberà,et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. , 1997, The European respiratory journal.
[7] J. Schwartz,et al. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. , 1997, The European respiratory journal.
[8] S. Holgate,et al. Mechanisms of virus induced exacerbations of asthma. , 1997, Thorax.
[9] S. Weiss,et al. Inhaled steroids and the risk of hospitalization for asthma. , 1997, JAMA.
[10] The British Guidelines on Asthma Management1995 Review and Position Statement , 1997 .
[11] P. Henricks,et al. Cell adhesion molecules and asthma , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[12] A. James,et al. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. , 1997, The European respiratory journal.
[13] P. Paré,et al. The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Canadian Combivent Study Group. , 1997, Chest.
[14] P. Sly,et al. Allergic respiratory disease: strategic targets for primary prevention during childhood. , 1997, Thorax.
[15] W. Busse,et al. Inhaled glucocorticoids in asthma : mechanisms and clinical actions , 1997 .
[16] E. R. Mcfadden,et al. The influence of parasympatholytics on the resolution of acute attacks of asthma. , 1997, The American journal of medicine.
[17] A. J. Block. CHEST Grades Out Considerably Well , 1996 .
[18] L Goldman,et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.
[19] D. Niewoehner,et al. Systemic corticosteroids in COPD. An unresolved clinical dilemma. , 1996, Chest.
[20] M. Chan-yeung,et al. Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma. , 1996, American journal of respiratory and critical care medicine.
[21] M J Campbell,et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. , 1996, American journal of respiratory and critical care medicine.
[22] C. Picado. Classification of severe asthma exacerbations: a proposal. , 1996, The European respiratory journal.
[23] J. Crowley,et al. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. , 1996, American journal of respiratory and critical care medicine.
[24] R. Beveridge,et al. Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society. , 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[25] S. Holgate,et al. Cellular infiltration of the airways in asthma of varying severity. , 1996, American journal of respiratory and critical care medicine.
[26] J. Fagon,et al. Severe exacerbations of COPD patients: the role of pulmonary infections. , 1996, Seminars in respiratory infections.
[27] A. Woolcock,et al. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. , 1996, American journal of respiratory and critical care medicine.
[28] J. Vestbo,et al. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. , 1996, American journal of respiratory and critical care medicine.
[29] S. Pingleton. Acute respiratory failure in chronic obstructive pulmonary disease. , 1996, Current opinion in pulmonary medicine.
[30] V. Hammersley,et al. The contribution of respiratory viruses to severe exacerbations of asthma in adults. , 1996, Chest.
[31] P. Ernst,et al. Canadian Asthma Consensus Conference Summary of Recommendations , 1996 .
[32] M. Gershwin,et al. Risk factors for asthmatic patients requiring intubation. III. Observations in young adults. , 1996, The Journal of asthma : official journal of the Association for the Care of Asthma.
[33] W. Knaus,et al. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. , 1996, JAMA.
[34] W. Knaus,et al. Hospital and 1-Year Survival of Patients Admitted to Intensive Care Units With Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 1995 .
[35] L. Fabbri,et al. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. , 1995, American journal of respiratory and critical care medicine.
[36] M. Sears,et al. Exacerbations of asthma without sputum eosinophilia. , 1995, Thorax.
[37] J C Yernault,et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.
[38] P. Moayyedi,et al. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease. , 1995, Thorax.
[39] B. Meyboom-de Jong,et al. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. , 1995, Thorax.
[40] Stephen T Holgate,et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.
[41] Arrighi Hm. US asthma mortality: 1941 to 1989. , 1995 .
[42] Kwang Woo Kim,et al. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. , 1995, The Journal of allergy and clinical immunology.
[43] E. Vittinghoff,et al. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. , 1995, JAMA.
[44] S. Johnston,et al. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. , 1995, American journal of respiratory and critical care medicine.
[45] R. Pistelli,et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. , 1995, The American journal of medicine.
[46] W. Morgan,et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. , 1995, The New England journal of medicine.
[47] G. Cochrane. Acute severe asthma: oxygen and high dose beta agonist during transfer for all? , 1995, Thorax.
[48] H. Arrighi. US asthma mortality: 1941 to 1989. , 1995, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[49] M. Gershwin,et al. Risk factors for intubation of adult asthmatic patients. , 1995, The Journal of asthma : official journal of the Association for the Care of Asthma.
[50] B. Make,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[51] R. S. St John,et al. Clinical features, management, and outcome of patients with severe asthma admitted to the intensive care unit. , 1995, The Journal of asthma : official journal of the Association for the Care of Asthma.
[52] M. Gershwin,et al. Risk factors for asthmatic patients requiring intubation. II. Observations in teenagers. , 1995, The Journal of asthma : official journal of the Association for the Care of Asthma.
[53] Ayne,et al. ASTHMA AND WHEEZING IN THE FIRST SIX YEARS OF LIFE , 1995 .
[54] W. Busse,et al. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. , 1994, The Journal of clinical investigation.
[55] L. Fabbri,et al. Airway eosinophilia in chronic bronchitis during exacerbations. , 1994, American journal of respiratory and critical care medicine.
[56] W. Bailey,et al. Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .
[57] P. Ind,et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid , 1994, The Lancet.
[58] K. R. Gray. Aminophylline in the treatment of acute asthma when B-2 adrenergics and steroids are provided , 1994 .
[59] K. Nicholson,et al. Respiratory viruses and exacerbations of asthma in adults. , 1993, BMJ.
[60] M. McDermott,et al. Aminophylline in the treatment of acute asthma when beta 2-adrenergics and steroids are provided. , 1993, Archives of internal medicine.
[61] L. Fabbri,et al. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group. , 1993, Thorax.
[62] S. Anderson,et al. Airway responsiveness : standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults , 1993 .
[63] A. James,et al. The structure of large and small airways in nonfatal and fatal asthma. , 1993, The American review of respiratory disease.
[64] A. Ciaccia. Comparison offluticasone propionate with beclomethasone dipropionate inmoderate to severeasthma treated for one year , 1993 .
[65] Z. Tomori,et al. Comparison of inspiratory effort in sniff-like aspiration reflex, gasping and normal breathing in cats. , 1993, The European respiratory journal.
[66] C E Reed,et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? , 1993, The American review of respiratory disease.
[67] J. Kemp,et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. , 1992, The New England journal of medicine.
[68] D. Postma,et al. European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. , 1992, The European respiratory journal.
[69] Alfred O. Berg,et al. Clinical Guidelines And Primary Care Guidelines For The Diagnosis And Management Of Asthma , 2012 .
[70] G. Guyatt,et al. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[71] M. Chan-yeung,et al. Reassessment of the temporal patterns of bronchial obstruction after exposure to occupational sensitizing agents. , 1991, The Journal of allergy and clinical immunology.
[72] E. Juniper,et al. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. , 1990, The American review of respiratory disease.
[73] S. Rennard,et al. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. , 1989, The American review of respiratory disease.
[74] D. Staunton,et al. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses , 1989, Cell.
[75] J. Bauer,et al. Stimulation by a bacterial extract (Broncho-Vaxom) of the metabolic and functional activities of murine macrophages. , 1989, International journal of immunopharmacology.
[76] D. Niewoehner,et al. Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial. , 1987, Annals of internal medicine.
[77] L. Reid. The presence or absence of bronchial mucus in fatal asthma. , 1987, The Journal of allergy and clinical immunology.
[78] N. Anthonisen,et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.
[79] Snider Gl. Chronic obstructive pulmonary disease--a continuing challenge. , 1986 .
[80] G. Snider. Chronic obstructive pulmonary disease--a continuing challenge. , 1986, The American review of respiratory disease.
[81] W. Thurlbeck,et al. The National Institutes of Health Intermittent Positive-Pressure Breathing trial: pathology studies. II. Correlation between morphologic findings, clinical findings, and evidence of expiratory air-flow obstruction. , 1985, The American review of respiratory disease.
[82] W. Thurlbeck,et al. The National Institutes of Health Intermittent Positive-Pressure Breathing trial: pathology studies. I. Interrelationship between morphologic lesions. , 1985, The American review of respiratory disease.
[83] L. Rosenhall,et al. High Dose Inhaled Budesonide in the Treatment of Severe Steroid‐Dependent Asthmatics , 1985, Allergy.
[84] R. Keller,et al. [Effect of an oral polyvalent bacterial lysate (Broncho-Vaxom) in chronic bronchitis]. , 1984, Praxis und Klinik der Pneumologie.
[85] G. Losa,et al. Clinical and immunobiological effects of an orally administered bacterial extract. , 1984, International journal of immunopharmacology.
[86] R. Peto,et al. The natural history of chronic airflow obstruction. , 1977, British medical journal.
[87] C. Fletcher. The Natural history of chronic bronchitis and emphysema: An eight-year study of early chronic obstructive lung disease in working men in London , 1976 .